基本情報
- CAS
61-71-2- 標準SMILES
O=C1Nc2ccccc2C1O- InChIKey
SGZFJWQQBHYNNF-UHFFFAOYSA-N- 分子式
- C8H7NO2
- 平均分子量
- 149.15 g/mol
- 単同位体質量
- 149.04767847
名称と識別子
- 優先名称
- Dioxindole
- IUPAC
- 3-hydroxy-1,3-dihydroindol-2-one
- 現地名
- 1,3-ジヒドロ-3-ヒドロキシ-2H-インドール-2-オン
- 英語名
- 3-Iodophenyl acetate
- 分子式
- C8H7NO2
- 分子量
- 149.15
名称と別名
名称をさらに表示
データベース識別子
- CAS
61-71-2- PubChem CID
- 6097
- DTXSID
DTXSID801018937- ChEMBL
CHEMBL2152717- ChEBI
CHEBI:28536- UNII
- NSL4M8FFA2
- EC Number
- 826-730-7
- Nikkaji
- J4.817H
物性
構造計算による物性
- XLogP
- 0.2
- 極性表面積
- 49.3 Ų
- 水素結合供与体数
- 2
- 水素結合受容体数
- 2
- 回転可能結合数
- 0
- 重原子数
- 11
- 形式電荷
- 0
- 複雑度
- 181
物理化学的性質
- 融点
- 167 · 167-168 °C
- 沸点
- 368.2 · 368.2±42.0 °C(Predicted)
- 比重(密度)
- 1.38 · 1.380±0.06 g/cm3(Predicted)
- 酸解離定数(Pka)
- 12.35 · 12.35±0.20(Predicted)
安全と法規制
GHS分類
GHS Classification
Warning
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral];H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation];H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation];H335 (100%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]
P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.
危険有害性情報
安全データ
- 危険有害性情報
- コード 危険有害性情報 危険有害性クラス 区分 注意喚起語 シンボル P コード H302
化学と産業
薬理情報
MeSH Pharmacological Classification
Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system.
A chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamines. (From Gilman, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p414)
サプライヤー4 社
補足説明
定義ChEBI: An oxindole that is 1,3-dihydro-2H-indol-2-one substituted by a hydroxy group at position 3.
関連反応
化合物ノート
読み込み中…